- Home
- NVCR vs USA Comparison
NVCR vs USA Comparison
Compare NVCR & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVCR | USA |
|---|---|---|
| Founded | 2000 | 1986 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCR | USA |
|---|---|---|
| Price | $13.14 | $6.19 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $28.42 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 880.5K |
| Earning Date | 10-30-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $642,269,000.00 | N/A |
| Revenue This Year | $9.75 | N/A |
| Revenue Next Year | $5.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.17 | N/A |
| 52 Week Low | $10.70 | $5.62 |
| 52 Week High | $34.13 | $7.09 |
Technical Indicators
Market Signals| Indicator | NVCR | USA |
|---|---|---|
| Relative Strength Index (RSI) | 58.20 | 52.63 |
| Support Level | $10.79 | $5.80 |
| Resistance Level | $13.94 | $6.20 |
| Average True Range (ATR) | 0.60 | 0.06 |
| MACD | 0.21 | 0.02 |
| Stochastic Oscillator | 75.18 | 84.53 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.